Loading clinical trials...
Loading clinical trials...
A Phase III, Randomized, Double-masked 6-month Trial to Compare the Efficacy and Safety of the Preservative-free Fixed-dose Combination of Tafluprost and Timolol Eye Drops to Those of Tafluprost and Timolol Eye Drops Given Concomitantly in Patients With Open Angle Glaucoma or Ocular Hypertension
Conditions
Interventions
Timolol and Tafluprost
Fixed Dose Combination of tafluprost and timolol
Locations
1
Hungary
Debrecen, Hungary
Start Date
March 1, 2011
Primary Completion Date
April 1, 2012
Completion Date
May 1, 2012
Last Updated
June 8, 2012
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
NCT06689696
Lead Sponsor
Santen Oy
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions